Enoxaparin 40Mg/0.4mL Prefilled Syringe

DRUG2 trials

Sponsors

Massachusetts General Hospital, Stanford University

Conditions

Anticoagulant-induced BleedingBone MetastasesBone SarcomaHematomaSarcomaSoft Tissue SarcomaVenous Thromboembolism

Phase 1

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

CompletedNCT04504318

Stanford UniversityVenous Thromboembolism

Start: 2020-08-12End: 2024-06-19Updated: 2025-06-22

Phase 4

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Enrolling by invitationNCT03244020

Massachusetts General HospitalAnticoagulant-induced Bleeding, Bone Metastases, Bone Sarcoma +4

Start: 2018-02-16End: 2028-07-01Target: 2868Updated: 2025-10-03